Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Trust

+ Add to Watchlist

XBMEX:US

41.38 USD 0.65 1.60%

As of 09:29:30 ET on 05/01/2015.

Snapshot for BlackRock Health Sciences Trust (XBMEX)

Year To Date: +8.96% 3-Month: +6.22% 3-Year: +26.17% 52-Week Range: 32.20 - 42.95
1-Month: +0.49% 1-Year: +31.96% 5-Year: +18.76% Beta vs SPX: 0.90

Mutual Fund Chart for XBMEX

No chart data available.
  • XBMEX:US 41.38
  • 1M
  • 1Y
Interactive XBMEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBMEX

Blackrock Health Sciences Trust is a non-diversified, closed-end management investment company incorporated in the USA. The Fund's objective is to provide total return through a combination of current income and capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Inception Date: 03-28-2005 Telephone: 1-800-882-0052
Managers: ERIN XIE / KYLE G MCCLEMENTS
Web Site: www.blackrock.com

Fundamentals for XBMEX

NAV (on 2015-05-01) 41.38
Assets (M) (on 2015-05-01) 328.03
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XBMEX

Dividend Type Income
Dividend Frequency Monthly
Last Dividend Net (on 2015-05-13) 0.17
Dividend Yield (ttm) 11.23

Fees & Expenses for XBMEX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.00
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.11

Top Fund Holdings for XBMEX

Filing Date: 12/31/2014
Name Position Value % of Total
Celgene Corp 94,086 10,524,460 3.471%
AbbVie Inc 150,184 9,828,041 3.241%
Biogen Inc 27,595 9,367,123 3.089%
Amgen Inc 57,500 9,159,175 3.021%
Alexion Pharmaceuticals Inc 48,960 9,059,069 2.988%
UnitedHealth Group Inc 85,634 8,656,741 2.855%
Johnson & Johnson 74,970 7,839,613 2.585%
Novartis AG 79,800 7,400,929 2.441%
Merck & Co Inc 130,000 7,382,700 2.435%
Actavis plc 27,724 7,136,435 2.353%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil